TEAMApril 13, 2026 at 2:02 PM UTCSoftware & Services

Atlassian's Stock Collapse Reflects AI Margin Woes and Cash Drain, But Cost Cuts Signal Profit Push

Read source article

What happened

Atlassian's shares have plunged to 2018 levels, trading at just over 2.5x sales despite over 20% revenue growth, as AI disruption fears and recent acquisitions pressure the stock. The company is implementing a 10% workforce reduction and cost-cutting to drive near-term profitability and self-fund AI investments, with restructuring charges estimated at $225–$236 million. However, net cash has fallen to $0.5 billion after acquisitions, raising concerns about capital allocation and limiting share buyback potential. SEC filings reveal that AI features like Rovo remain bundled 'at no additional cost,' continuing to negatively impact operating margins without corresponding revenue increases. The forced Data Center to Cloud migration, starting March 2026, adds quarterly volatility, making the next 6–12 months critical for monitoring restructuring outcomes and AI monetization progress.

Implication

Atlassian's low valuation multiple underscores deep market skepticism over its ability to monetize AI and navigate the costly Cloud transition, despite strong top-line growth. Cost reductions could boost near-term margins, but if AI stays bundled, rising hosting costs may continue to erode profits without revenue uplift. The reduced cash balance limits financial flexibility, increasing reliance on operational execution and raising execution risks amid restructuring. Success hinges on converting AI usage into paid packaging and smoothing migration volatility, but filings warn of ongoing 'fluctuations' and margin headwinds. Until these fundamentals improve, the WAIT rating is justified, with an attractive entry point below $70 offering better risk-adjusted returns.

Thesis delta

The new article highlights increased capital allocation risks from lower net cash and near-term profit potential from cost cuts, but it does not alter the core investment thesis. The DeepValue report's WAIT stance remains valid, as AI bundling and migration volatility—key thesis breakers—persist without resolution. Investors should still await disclosures on AI pricing and restructuring completion before reassessing the call.

Confidence

Medium